ATG-201
ATG-201 is a novel T-cell engager (TCE). ATG-201 exhibits CD19-dependent CD3 binding and activation properties, enabling the effective depletion of B cells. ATG-201 can be used to study B-cell malignancies and B-cell-related autoimmune diseases.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Species Reactivity
Human
Target
CD3 & CD19
Conjugated
Unconjugated
Application
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[ATG-201]
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)